Differences
This shows you the differences between two versions of the page.
staff:martin [2013-10-21 16:52] |
staff:martin [2015-02-04 20:26] |
||
---|---|---|---|
Line 4: | Line 4: | ||
==== Marcel Martin ==== | ==== Marcel Martin ==== | ||
- | | Room: | 209 | | ||
- | | Phone: | +49 231 755-7745 | | ||
- | | Fax: | +49 231 755-7740 | | ||
| E-Mail: | marcel //dot// martin //at// tu //dash// dortmund //dot// de | | | E-Mail: | marcel //dot// martin //at// tu //dash// dortmund //dot// de | | ||
| ORCID: | http://orcid.org/0000-0002-0680-200X | | | ORCID: | http://orcid.org/0000-0002-0680-200X | | ||
Line 84: | Line 81: | ||
//Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome//\\ | //Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome//\\ | ||
//British Journal of Cancer//, 2012, 107(8):1409-1417.\\ | //British Journal of Cancer//, 2012, 107(8):1409-1417.\\ | ||
- | DOI: [[http://dx.doi.org/10.1038/bjc.2012.391]] | + | DOI: [[http://dx.doi.org/10.1038/bjc.2012.391|10.1038/bjc.2012.391]] |
Alexander Schramm, Johannes Köster, Tobias Marschall, Marcel Martin, Melanie Schwermer, Kathrin Fielitz, Gabriele Büchel, Matthias Barann, Daniela Esser, Philip Rosenstiel, Sven Rahmann, Angelika Eggert, Johannes H. Schulte\\ | Alexander Schramm, Johannes Köster, Tobias Marschall, Marcel Martin, Melanie Schwermer, Kathrin Fielitz, Gabriele Büchel, Matthias Barann, Daniela Esser, Philip Rosenstiel, Sven Rahmann, Angelika Eggert, Johannes H. Schulte\\ | ||
//Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma//\\ | //Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma//\\ | ||
In //International Journal of Cancer, 2012//\\ | In //International Journal of Cancer, 2012//\\ | ||
- | DOI: [[http://dx.doi.org/10.1002/ijc.27787]] | + | DOI: [[http://dx.doi.org/10.1002/ijc.27787|10.1002/ijc.27787]] |
Jing-Woei Li, Keith Robison, Marcel Martin, Andreas Sjödin, Björn Usadel, Matthew Young, Eric C. Olivares, Dan M. Bolser.\\ | Jing-Woei Li, Keith Robison, Marcel Martin, Andreas Sjödin, Björn Usadel, Matthew Young, Eric C. Olivares, Dan M. Bolser.\\ | ||
//SEQanswers wiki: a wiki database of tools for high-throughput sequencing analysis//\\ | //SEQanswers wiki: a wiki database of tools for high-throughput sequencing analysis//\\ | ||
Nucleic Acids Research, 2012, 40(D1):D1313-D1317.\\ | Nucleic Acids Research, 2012, 40(D1):D1313-D1317.\\ | ||
- | DOI: [[http://dx.doi.org/10.1093/nar/gkr1058]] | + | DOI: [[http://dx.doi.org/10.1093/nar/gkr1058|10.1093/nar/gkr1058]] |
Marcel Martin.\\ | Marcel Martin.\\ | ||
//[[http://journal.embnet.org/index.php/embnetjournal/article/view/200|Cutadapt removes adapter sequences from high-throughput sequencing reads]]//\\ | //[[http://journal.embnet.org/index.php/embnetjournal/article/view/200|Cutadapt removes adapter sequences from high-throughput sequencing reads]]//\\ | ||
- | In //EMBnet.journal//, 17, May 2011 | + | In //EMBnet.journal//, 17, May 2011\\ |
+ | DOI: [[http://dx.doi.org/10.14806/ej.17.1.200|10.14806/ej.17.1.200]] | ||
Johannes H. Schulte, Tobias Marschall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh, Stefanie Schlierf, Theresa Thor, Jo Vandesompele, Angelika Eggert, Stefan Schreiber, Sven Rahmann and Alexander Schramm.\\ | Johannes H. Schulte, Tobias Marschall, Marcel Martin, Philipp Rosenstiel, Pieter Mestdagh, Stefanie Schlierf, Theresa Thor, Jo Vandesompele, Angelika Eggert, Stefan Schreiber, Sven Rahmann and Alexander Schramm.\\ |